SI
Sigachi Industries Ltd (SIGACHI)
₹30.57
Mkt cap
₹1,093 Cr
P/E ratio
43.70
P/B
2.37
Div yield
0.35%
ROE
7.37%
ROCE
6.87%
EPS (TTM)
₹0.70
Book value
₹13
52W range
17–41
Sector
Healthcare
Price history
Previous close
Incorporated in 1989, Sigachi Industries Ltd is a manufacturing and selling of MCC. [1]
NSE SIGACHIBSE 543389
Health check
Mixed
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsBullish
52-week range
−25.07% from high₹31
₹17+83.60% from low₹41
Current
₹30.57
Prev close
₹27.56
Day
+10.92%
Price performance
1D
+11.36%
1W
+7.76%
1M
+18.27%
3M
+1.25%
6M
+50.51%
1Y
−13.74%
YTD
−2.46%
Financials
Revenue, profit & margin
P/E ratio
43.7×
SIGACHI is 31% above the sector median of 33.4×
SIGACHI43.7×
Sector median33.4×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 84.70 | 99.18 | 110.95 | 104.13 | 95.71 | 124.90 | 139.42 | 128.20 | 128.25 | 110.48 | 117.21 | 121.90 | 121.27 | |
| Expenses | 68.39 | 77.76 | 88.36 | 87.80 | 74.69 | 107.67 | 106.25 | 99.65 | 104.14 | 102.96 | 111.49 | 105.49 | 104.76 | |
| Operating Profit | 16.31 | 21.42 | 22.59 | 16.33 | 21.02 | 17.23 | 33.17 | 28.55 | 24.11 | 7.52 | 5.72 | 16.41 | 16.51 | |
| OPM % | 19.26% | 21.60% | 20.36% | 15.68% | 21.96% | 13.80% | 23.79% | 22.27% | 18.80% | 6.81% | 4.88% | 13.46% | 13.61% | |
| Other Income | 1.63 | 1.11 | 1.71 | 7.24 | 1.68 | 14.64 | 2.02 | 2.19 | -117.07 | 7.15 | -0.26 | 0.21 | 1.00 | |
| Interest | 1.27 | 1.79 | 1.84 | 2.87 | 3.16 | 2.10 | 3.82 | 3.33 | 3.31 | 3.13 | 3.13 | 4.33 | 3.01 | |
| Depreciation | 1.96 | 2.52 | 2.82 | 3.49 | 3.15 | 3.22 | 4.67 | 4.74 | 4.72 | 4.11 | 4.18 | 4.57 | 4.41 | |
| Profit before tax | 14.71 | 18.22 | 19.64 | 17.21 | 16.39 | 26.55 | 26.70 | 22.67 | -100.99 | 7.43 | -1.85 | 7.72 | 10.09 | |
| Tax % | 26.04% | 17.01% | 18.02% | 11.85% | 22.21% | 20.83% | 23.22% | 28.67% | -0.02% | -41.59% | -98.92% | 0.78% | 19.33% | |
| Net Profit | 10.88 | 15.12 | 16.10 | 15.17 | 12.76 | 21.01 | 20.51 | 16.18 | -100.97 | 10.53 | -0.01 | 7.65 | 8.15 | |
| EPS in Rs | 0.35 | 0.49 | 0.50 | 0.46 | 0.40 | 0.65 | 0.64 | 0.35 | -2.63 | 0.28 | 0.01 | 0.20 | 0.18 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −1.76% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 13 Aug '26◦ |
| Earnings day | −1.76% |
| +1 day | −5.11% |
| +5 days | +8.21% |
| +15 days | +25.10% |
| +30 days | +3.60% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Sep 202636.69%Promoter
Promoters36.69%
FIIs0.52%0.73
DIIs0.05%0.05
Public62.74%0.69
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,870.00 | 36.46 | 4,48,676 | 0.86% | 1,995 | −10.53% | 16,199 | +11.88% | 20.53% |
| Divi's Lab. | ₹11,150.00 | 86.62 | 2,95,997 | 0.27% | 1,127 | +63.57% | 3,676 | +35.40% | 21.97% |
| Torrent Pharma. | ₹4,668.80 | 81.80 | 1,77,586 | 0.81% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,338.00 | 94.28 | 1,26,325 | 0.09% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,204.20 | 26.51 | 1,20,119 | 0.08% | 928 | −27.96% | 7,910 | +29.17% | 21.14% |
| Dr Reddy's Labs | ₹1,388.00 | 41.41 | 1,15,936 | 0.58% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,388.00 | 36.11 | 1,12,135 | 0.94% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| Sigachi Indust. | ₹28.61 | 43.66 | 1,093 | 0.35% | 9 | +26.48% | 113 | +35.19% | 6.87% |
| Median: 160 Co. | ₹445.73 | 33.35 | 2,016 | 0.08% | 13 | +33.73% | 179 | +21.23% | 14.94% |
Filings
Annual reports6
Concall transcripts51
TranscriptNov 2026PPTNov 2026RECNov 2026TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptJun 2026PPTJun 2026RECJun 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptOct 2025PPTOct 2025RECOct 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptJun 2025PPTJun 2025RECJun 2025TranscriptJan 2025PPTJan 2025TranscriptNov 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Monitoring Agency Report 12 Nov - Monitoring agency report filed for IPO proceeds utilization for quarter ended September 30, 2026.Revision In Outcome Of Board Meeting 31.10.2026 5 Nov - Revised limited review report for Q2 FY2027; corrected reporting period to 30.09.2026.Announcement under Regulation 30 (LODR)-Earnings Call Transcript 5 NovAnnouncement under Regulation 30 (LODR)-Newspaper Publication 2 Nov - Newspaper Publication of Financial Results for quarter ended 30.09.2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 31 Oct - Q2 FY 2026-27 earnings call audio recording is available on Sigachi’s website.






